[{"NetIncomeLoss_1_Q2_USD":-81405000.0,"LiabilitiesFairValueDisclosure_0_Q2_USD":50800000.0,"PrepaidExpenseNoncurrent_0_Q2_USD":2077000.0,"NetCashProvidedByUsedInInvestingActivities_2_Q2_USD":477725000.0,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q2_USD":2000.0,"InterestPaidNet_2_Q2_USD":27780000.0,"BilledContractReceivables_0_Q2_USD":127050000.0,"AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation_1_Q2_USD":1432000.0,"BusinessCombinationContingentConsiderationLiability_0_Q2_USD":50800000.0,"AccruedLiabilitiesCurrent_0_Q2_USD":240141000.0,"CommitmentsAndContingencies_0_Q2_USD":null,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_1_Q2_shares":79746000.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_2_Q2_shares":79601000.0,"AccruedRoyaltiesCurrent_0_Q2_USD":9201000.0,"PreferredStockSharesOutstanding_0_Q2_shares":0.0,"InventoryFinishedGoodsNetOfReserves_0_Q2_USD":29471000.0,"PrepaidTaxes_0_Q2_USD":894000.0,"AssetsCurrent_0_Q2_USD":2265217000.0,"PaymentsToAcquireAvailableForSaleSecuritiesDebt_2_Q2_USD":29989000.0,"ShareBasedCompensation_2_Q2_USD":57477000.0,"OtherComprehensiveIncomeLossNetOfTax_1_Q2_USD":5000.0,"OtherComprehensiveIncomeLossNetOfTax_2_Q2_USD":-1000.0,"Assets_0_Q2_USD":2759073000.0,"ProceedsFromSaleOfIntangibleAssets_2_Q2_USD":102000000.0,"CommonStockSharesIssued_0_Q2_shares":79830411.0,"OtherNoncashIncomeExpense_2_Q2_USD":-3786000.0,"ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities_2_Q2_USD":436000000.0,"GainLossOnDispositionOfIntangibleAssets_2_Q2_USD":102000000.0,"StockIssuedDuringPeriodValueStockOptionsExercised_1_Q2_USD":3526000.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_1_Q2_shares":9800000.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_2_Q2_shares":10000000.0,"SellingGeneralAndAdministrativeExpense_1_Q2_USD":72347000.0,"SellingGeneralAndAdministrativeExpense_2_Q2_USD":143478000.0,"GainLossOnDispositionOfIntangibleAssets_1_Q2_USD":102000000.0,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_1_Q2_USD":5000.0,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_2_Q2_USD":-1000.0,"Liabilities_0_Q2_USD":2273965000.0,"RestrictedCashAndInvestmentsNoncurrent_0_Q2_USD":9315000.0,"Revenues_1_Q2_USD":164089000.0,"Revenues_2_Q2_USD":311020000.0,"CommonStockValue_0_Q2_USD":8000.0,"IncreaseDecreaseInDeferredRevenue_2_Q2_USD":-44255000.0,"IncomeTaxExpenseBenefit_1_Q2_USD":-354000.0,"AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition_1_Q2_USD":28969000.0,"IncomeTaxExpenseBenefit_2_Q2_USD":-497000.0,"OtherNonoperatingIncomeExpense_1_Q2_USD":-427000.0,"OtherNonoperatingIncomeExpense_2_Q2_USD":-499000.0,"AssetsFairValueDisclosure_0_Q2_USD":1452558000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q2_shares":79746000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_2_Q2_shares":79601000.0,"ShortTermInvestments_0_Q2_USD":30000000.0,"AccountsReceivableNetCurrent_0_Q2_USD":127520000.0,"InterestPayableCurrent_0_Q2_USD":1045000.0,"DepreciationDepletionAndAmortization_2_Q2_USD":17377000.0,"ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost_2_Q2_USD":434771000.0,"AdditionalPaidInCapitalCommonStock_0_Q2_USD":3521721000.0,"OperatingLeaseLiabilityNoncurrent_0_Q2_USD":65285000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q2_USD":1697275000.0,"OtherAssetsNoncurrent_0_Q2_USD":203553000.0,"AmortizationOfIntangibleAssets_1_Q2_USD":179000.0,"AmortizationOfIntangibleAssets_2_Q2_USD":349000.0,"ComprehensiveIncomeNetOfTax_1_Q2_USD":-81400000.0,"ComprehensiveIncomeNetOfTax_2_Q2_USD":-248656000.0,"IncreaseDecreaseInInventories_2_Q2_USD":36795000.0,"OtherAssetsCurrent_0_Q2_USD":141666000.0,"CashCashEquivalentsAndShortTermInvestments_0_Q2_USD":1736600000.0,"CostsAndExpenses_1_Q2_USD":331663000.0,"CostsAndExpenses_2_Q2_USD":630459000.0,"NetCashProvidedByUsedInFinancingActivities_2_Q2_USD":6419000.0,"ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost_1_Q2_USD":239622000.0,"OperatingLeaseRightOfUseAsset_0_Q2_USD":72868000.0,"LongTermLoansPayable_0_Q2_USD":1092985000.0,"PreferredStockParOrStatedValuePerShare_0_Q2_USD":0.0001,"DebtInstrumentFaceAmount_0_Q2_USD":1119993000.0,"InterestExpense_2_Q2_USD":31482000.0,"NonoperatingIncomeExpense_1_Q2_USD":85815000.0,"NonoperatingIncomeExpense_2_Q2_USD":70287000.0,"AccountsPayableCurrent_0_Q2_USD":76681000.0,"LiabilitiesCurrent_0_Q2_USD":425022000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q2_shares":79746000.0,"InterestExpense_1_Q2_USD":15831000.0,"WeightedAverageNumberOfSharesOutstandingBasic_2_Q2_shares":79601000.0,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":-289517000.0,"RevenueFromCollaborativeArrangementExcludingRevenueFromContractWithCustomer_1_Q2_USD":22250000.0,"RevenueFromCollaborativeArrangementExcludingRevenueFromContractWithCustomer_2_Q2_USD":44255000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_1_Q2_USD":-81759000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_2_Q2_USD":-249152000.0,"RestrictedCashNoncurrent_0_Q2_USD":9065000.0,"InventoryRawMaterialsNetOfReserves_0_Q2_USD":47774000.0,"NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1_2_Q2_USD":7760000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0_Q2_USD":1706340000.0,"OtherAccruedLiabilitiesCurrent_0_Q2_USD":4346000.0,"NetIncomeLoss_2_Q2_USD":-248655000.0,"PropertyPlantAndEquipmentNet_0_Q2_USD":203330000.0,"PreferredStockSharesIssued_0_Q2_shares":0.0,"PrepaidInsurance_0_Q2_USD":2660000.0,"GovernmentContractReceivable_0_Q2_USD":470000.0,"LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_0_Q2_USD":250000000.0,"ProceedsFromStockOptionsExercised_2_Q2_USD":12752000.0,"NumberOfOperatingSegments_2_Q2_Segment":1.0,"OtherAssetsMiscellaneousNoncurrent_0_Q2_USD":3416000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_0_Q2_USD":1706340000.0,"CashEquivalentsAtCarryingValue_0_Q2_USD":1382337000.0,"IncrementalCommonSharesAttributableToCallOptionsAndWarrants_1_Q2_shares":0.0,"IncrementalCommonSharesAttributableToCallOptionsAndWarrants_2_Q2_shares":0.0,"IncreaseDecreaseInOtherOperatingAssets_2_Q2_USD":-73670000.0,"FiniteLivedIntangibleAssetsNet_0_Q2_USD":14105000.0,"CommonStockSharesOutstanding_0_Q2_shares":79830411.0,"IncreaseDecreaseInAccountsReceivable_2_Q2_USD":26180000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_2_Q2_USD":194627000.0,"PreferredStockValue_0_Q2_USD":null,"ContractWithCustomerLiabilityCurrent_0_Q2_USD":89244000.0,"InvestmentIncomeInterest_1_Q2_USD":52000.0,"InvestmentIncomeInterest_2_Q2_USD":111000.0,"InventoryNet_0_Q2_USD":268756000.0,"OtherAssetsMiscellaneousCurrent_0_Q2_USD":4905000.0,"LiabilitiesAndStockholdersEquity_0_Q2_USD":2759073000.0,"OtherNonoperatingExpense_1_Q2_USD":16185000.0,"AvailableForSaleSecuritiesDebtSecuritiesCurrent_0_Q2_USD":30000000.0,"OperatingIncomeLoss_1_Q2_USD":-167574000.0,"OperatingIncomeLoss_2_Q2_USD":-319439000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_1_Q2_USD":141839000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_2_Q2_USD":266765000.0,"CommonStockSharesAuthorized_0_Q2_shares":198000000.0,"OtherNonoperatingExpense_2_Q2_USD":31713000.0,"EmployeeRelatedLiabilitiesCurrent_0_Q2_USD":31222000.0,"PreferredStockSharesAuthorized_0_Q2_shares":3333333.0,"InventoryWorkInProcessAndRawMaterialsNetOfReserves_0_Q2_USD":191511000.0,"RetainedEarningsAccumulatedDeficit_0_Q2_USD":-3036623000.0,"AllowanceForDoubtfulAccountsReceivableCurrent_0_Q2_USD":56061000.0,"PaymentsToAcquirePropertyPlantAndEquipment_2_Q2_USD":27043000.0,"ContractWithCustomerLiabilityNoncurrent_0_Q2_USD":619233000.0,"StockholdersEquity_0_Q2_USD":485108000.0,"OtherLiabilitiesCurrent_0_Q2_USD":18956000.0,"OtherLiabilitiesNoncurrent_0_Q2_USD":20640000.0,"ProfitLoss_2_Q2_USD":-248655000.0,"EarningsPerShareBasicAndDiluted_1_Q2_USD":-1.02,"EarningsPerShareBasicAndDiluted_2_Q2_USD":-3.12,"RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_2_Q2_USD":10582000.0,"OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToNoncontrollingInterest_1_Q2_USD":5000.0,"AllocatedShareBasedCompensationExpense_1_Q2_USD":28969000.0,"AllocatedShareBasedCompensationExpense_2_Q2_USD":57477000.0,"LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_0_Q2_USD":869993000.0,"CommonStockParOrStatedValuePerShare_0_Q2_USD":0.0001,"AccruedProfessionalFeesCurrent_0_Q2_USD":8648000.0,"Ticker":"SRPT","CIK":"873303","name":"SAREPTA THERAPEUTICS, INC.","OfficialName":"Sarepta Therapeutics Inc. Common Stock (DE)","form":"10-Q","period":"20210630","fy":"2021.0","fp":"Q2","qtrs":"1","uom":"USD","footnote":"nan","Market Cap":"7117506934.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20210804"}]